TickerFactsScreenerDevelopers

AIM ImmunoTech Inc. (AIM) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$13.26M2010: -$16.39M2011: -$14.29M2012: -$20.34M2013: -$17.17M2014: -$19.10M2015: -$16.65M2016: -$13.80M2017: -$11.42M2018: -$11.50M2019: -$12.44M2020: -$15.15M2021: -$18.84M2022: -$19.92M2023: -$31.92M2024: -$19.77M2025: -$11.66M-$11.66M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$11.66M+41.0%
2024-$19.77M+38.0%
2023-$31.92M-60.2%
2022-$19.92M-5.8%
2021-$18.84M-24.3%
2020-$15.15M-21.8%
2019-$12.44M-8.2%
2018-$11.50M-0.7%
2017-$11.42M+17.3%
2016-$13.80M+17.1%
2015-$16.65M+12.8%
2014-$19.10M-11.3%
2013-$17.17M+15.6%
2012-$20.34M-42.3%
2011-$14.29M+12.8%
2010-$16.39M-23.5%
2009-$13.26M—